Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature

Overview

Journal Intern Med

Specialty General Medicine

Date 2017 Jul 19

PMID 28717078

Citations 10

Authors

Jen-Wei Chou

Yin-Lan Lin

Ken-Sheng Cheng

Po-Yuan Wu

Teressa Reanne Ju

Affiliations

Soon will be listed here.

Abstract

Dermatomyositis or polymyositis as a paraneoplastic syndrome of hepatocellular carcinoma (HCC) is an uncommon event. Few cases have been reported in the literature. We herein report the case of a 55-year-old man with chronic hepatitis B and alcoholism who presented with skin rash. Abdominal computed tomography revealed multiple hypervascular liver tumors consistent with HCC. He subsequently developed dysphagia with proximal limb weakness. Laboratory tests and electromyography demonstrated inflammatory myopathy. We therefore diagnosed the patient with HCC-induced dermatomyositis. Prednisolone and anti-viral therapy were administered; however, the patient died two months later due to the progression of the disease. We review the cases of HCC-induced dermatomyositis and polymyositis in the literature.

Citing Articles

Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. A Systematic Review and Meta-analysis.

Al-Showbaki L, Toubasi A, Jaber D, Al Shdifat M, Al-Maani N, Qudah O J Cancer. 2024; 15(4):1021-1029.

PMID: 38230223 PMC: 10788718. DOI: 10.7150/jca.88931.

Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma.

Ueda Y, Shimada K Rheumatol Adv Pract. 2023; 7(2):rkad066.

PMID: 37564124 PMC: 10409891. DOI: 10.1093/rap/rkad066.

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence.

Ferronato M, Lalanne C, Quarneti C, Cevolani M, Ricci C, Granito A J Clin Transl Hepatol. 2022; 11(1):253-259.

PMID: 36406323 PMC: 9647099. DOI: 10.14218/JCTH.2021.00573.

Autoimmune liver diseases in systemic rheumatic diseases.

Wang C, Tsai H World J Gastroenterol. 2022; 28(23):2527-2545.

PMID: 35949355 PMC: 9254143. DOI: 10.3748/wjg.v28.i23.2527.

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.

Hu H, Yang H, Liu Y, Yan B Front Med (Lausanne). 2022; 8:833114.

PMID: 35141258 PMC: 8818857. DOI: 10.3389/fmed.2021.833114.

References

Shlomai A, de Jong Y, Rice C . Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014; 26:78-88. PMC: 4048791. DOI: 10.1016/j.semcancer.2014.01.004. View

Ferri C, Antonelli A, Mascia M, Sebastiani M, Fallahi P, Ferrari D . HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis. 2007; 39 Suppl 1:S13-21. DOI: 10.1016/s1590-8658(07)80005-3. View

Sigurgeirsson B, Lindelof B, Edhag O, Allander E . Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992; 326(6):363-7. DOI: 10.1056/NEJM199202063260602. View

Hasegawa K, Uesugi H, Kubota K, Ugawa Y, Murayama S, Kobayashi T . Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology. 2000; 47(35):1425-7. View

Kishore D, Khurana V, Raj A, Gambhir I, Diwaker A . Hepatocellular carcinoma presenting as polymyositis: a paraneoplastic syndrome. Ann Saudi Med. 2011; 31(5):533-5. PMC: 3183691. DOI: 10.4103/0256-4947.84636. View

Thanapirom K, Aniwan S, Treeprasertsuk S . Polymyositis Associated with Hepatitis B Virus Cirrhosis and Advanced Hepatocellular Carcinoma. ACG Case Rep J. 2015; 1(3):167-9. PMC: 4435311. DOI: 10.14309/crj.2014.39. View

Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P . Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis. 2010; 13(2):117-24. DOI: 10.1111/j.1756-185X.2010.01472.x. View

Satoh M, Tanaka S, Ceribelli A, Calise S, Chan E . A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. Clin Rev Allergy Immunol. 2015; 52(1):1-19. PMC: 5828023. DOI: 10.1007/s12016-015-8510-y. View

Kao L, Chung L, Fiorentino D . Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep. 2011; 13(3):225-32. DOI: 10.1007/s11926-011-0166-x. View

10.

Gray R, Altman R, Gottlieb N . Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma. J Rheumatol. 1976; 3(3):227-32. View

11.

Qu Q, Wang S, Chen S, Zhou L, Rui J . Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. Am Surg. 2014; 80(2):191-6. View

12.

Aggarwal R, Oddis C . Therapeutic advances in myositis. Curr Opin Rheumatol. 2012; 24(6):635-41. DOI: 10.1097/BOR.0b013e328358ac72. View

13.

Horie Y, Yamada M, Nakai K, Kawasaki H, Hirayama C, Matsui K . Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol. 1989; 4(1):101-4. DOI: 10.1111/j.1440-1746.1989.tb00812.x. View

14.

Sultan S, Isenberg D . Re-classifying myositis. Rheumatology (Oxford). 2009; 49(5):831-3. DOI: 10.1093/rheumatology/kep355. View

15.

Gomez A, Solans R, Simeon C, Selva A, Garcia F, Fonollosa V . Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al. Arthritis Rheum. 1997; 40(2):394-5. DOI: 10.1002/art.1780400232. View

16.

Vautravers C, Rat P, Cercueil J, Moreau T, Horiot J, Chauffert B . Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis. Eur J Intern Med. 2008; 19(8):e86-7. DOI: 10.1016/j.ejim.2008.04.014. View

17.

Kee S, Kim T, Lee S, Cho Y, Park S, Kim J . Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int. 2008; 29(5):595-9. DOI: 10.1007/s00296-008-0718-1. View

18.

Tekaya R, Abdelghni K, Abdelmoula L, Ben Hadj Yahia C, Chaabouni L, Zouari R . Hepatocellular carcinoma with polymyositis as an initial symptom: a case report. Acta Clin Belg. 2011; 66(1):53-4. DOI: 10.2143/ACB.66.1.2062515. View

19.

Kim M, Kim J, Sung M, Min J . Hepatocellular carcinoma,polymyositis,rhabdomyolysis,and acute renal failure. J Korean Med Sci. 2004; 19(6):891-4. PMC: 2816294. DOI: 10.3346/jkms.2004.19.6.891. View

20.

Leaute-Labreze C, Perel Y, Taieb A . Childhood dermatomyositis associated with hepatocarcinoma. N Engl J Med. 1995; 333(16):1083. DOI: 10.1056/NEJM199510193331615. View